MetLife Investment Management’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.2K Hold
5,908
﹤0.01% 2563
2025
Q4
$109K Buy
+5,908
New +$108K ﹤0.01% 2566
2025
Q3
Sell
-5,181
Closed -$100K 2890
2025
Q2
$100K Hold
5,181
﹤0.01% 2537
2025
Q1
$80.4K Sell
5,181
-105
-2% -$1.88K ﹤0.01% 2609
2024
Q4
$94.1K Buy
5,286
+340
+7% +$5.86K ﹤0.01% 2648
2024
Q3
$89.3K Buy
+4,946
New +$90.3K ﹤0.01% 2667

Other funds holding MDWD

MetLife Investment Management's MDWD Position: Q1 2026 in Review

MetLife Investment Management held its MediWound (MDWD) position steady in Q1 2026 at 5,908 shares worth $95.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

MetLife Investment Management first reported a position in MDWD in Q3 2024 and has held it in 6 quarters since. The position peaked at $109K in Q4 2025. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

  • MetLife Investment Management held 5,908 shares of MediWound worth $95.2K as of Q1 2026.
  • MetLife Investment Management left its MediWound share count unchanged in Q1 2026.
  • MediWound made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2563 holding.
  • MetLife Investment Management first reported a position in MediWound in Q3 2024 and has held it in 6 quarters since.
  • MetLife Investment Management's MediWound position peaked at $109K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.